Table 1.
Control group | Group A (Tachosil) | Group B (Surgicel Fibrillar) | Group C (Surgicel Snow) | p-value | |
---|---|---|---|---|---|
Foreign body giant cell | 0 | 0 | 0 | 0 | - |
Inflammatory cell infiltration | 2.00 ± 0.00 | 2.33 ± 0.58 | 2.00 ± 0.00 | 2.33 ± 0.58 | 0.680 |
Granulation tissue | 2.00 ± 0.00 | 2.00 ± 0.00 | 2.00 ± 0.00 | 2.00 ± 0.00 | - |
Fibroblast proliferation | 1.00 ± 0.00 | 2.00 ± 0.00 | 1.00 ± 0.00 | 1.00 ± 0.00 | 0.029 |
Neovascularization | 1.00 ± 0.00 | 1.00 ± 0.00 | 1.00 ± 0.00 | 1.00 ± 0.00 | - |
ECM formation | 1.00 ± 0.00 | 3.00 ± 0.00 | 3.00 ± 0.00 | 3.00 ± 0.00 | 0.029 |
Striated muscle repair | 0.50 ± 0.71 | 3.00 ± 0.00 | 1.50 ± 0.71 | 1.67 ± 0.58 | 0.057 |
Values are presented as mean±SD. Scoring: 0, absent; 1, slight; 2, moderate; 3, extensive.
ECM, extracellular matrix.
p-values <0.05 considered statistically significant.